
Celgene has invested $1 billion into Juno Therapeutics as part of a 10-year partnership aiming to study cures for cancer …

Eli Lilly is teaming up again with UK biotech Immunocore in order to work together on immunotherapy-based clinical trials. Specifically …

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended several treatments for marketing …

Canadian drugmaker Valeant Pharmaceuticals has made a move to acquire animal health company Zoetis. This is according to the Wall …

AstraZeneca vice president James Ward-Lilley and Takeda’s chief financial officer François-Xavier Roger are both exiting their respective companies and moving …

Google has developed a health-tracking wearable that is not for the consumer market but rather designed to be utilised in …

Sun Pharma has asked 18 executives to leave the company who were previously a part of Ranbaxy, the firm it …

Health and fitness wearable device Fitbit has beaten expectations as the company’s shares soar following its first day of trading …

The National Institute for Health and Care Excellence has not recommended Gilead’s leukaemia drug Zydelig in draft guidance. But the …
Sanofi and Merck are looking forward to a successor to their blockbuster Gardasil now that the European Commission has granted …

NHS England has laid out digital technology plans that it says will completely transform services and improve health outcomes using …

Pfizer says it has broken ground with a $95 million production facility in Suzhou in China to expand its production …

Consumer watchdog Public Citizen has criticised the FDA for incorrectly expanding the use of Vanda Pharma’s sleep disorder drug Hetlioz …

The chairman of the NHS procurement and efficiency board Lord Carter has said the UK health body could save billions …

British private investigator Peter Humphrey who worked for GlaxoSmithKline has been released from a Chinese jail following his conviction last …